Tizanidine Hydrochloride Capsule
Product Images NDC 80425-0448

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tizanidine Hydrochloride (NDC 80425-0448). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tizanidine HCl 6mg Capsule #30 (Tizanidine HCl 6mg 80425 0448 01)

This is a product label for Tizanidine HCL 6mg capsules, with 30 capsules per bottle. The medication is a generic version of Zanaflex. The lot number is XXXKXX, with an expiration date of 7/31/2027. The product is manufactured by Genus Pharmaceuticals. Store at a temperature between 20°-25°C (68°-77°F).*

FDA Label Image

Tizanidine HCl 6mg Capsule #60 (Tizanidine HCl 6mg 80425 0448 02)

This is a medication information for Tizanidine HCL 6mg capsules under the brand name Zanaflex. The batch number, expiration date, and other details are provided for tracking purposes. Additionally, the manufacturer is noted as "Ingenus Pharmaceuticals."*

FDA Label Image

Tizanidine HCl 6mg Capsule #90 (Tizanidine HCl 6mg 80425 0448 03)

This text provides information about a medication called Tizanidine HCL 6mg capsule, with a quantity of 90 capsules. It is a generic version of the brand Zanaflex. The medication is packed by S s 20035 M7 and has an expiration date of 7/31/2027. The source NDC is 50742-0226-15 with an NDC of 80425-0448-03. The lot number is not visible (XXXXXX) and the manufacturer is Ingenus Pharmaceuticals. Additionally, the text mentions the expiration date as 7/31/2037.*

FDA Label Image

Tizanidine Structure (Fe05ad15 Db11 4d9e 9fb8 721cec4633d9 01)

FDA Label Image

Figure 1 (Fe05ad15 Db11 4d9e 9fb8 721cec4633d9 02)

FDA Label Image

Figure 2 (Fe05ad15 Db11 4d9e 9fb8 721cec4633d9 03)

FDA Label Image

Figure 3 (Fe05ad15 Db11 4d9e 9fb8 721cec4633d9 04)

This text mentions the improvement in the Ashworth Score. It appears to discuss the use of Tizanidine at a mean dose of 26.8 mg and references titration, maintenance, and endpoint data from a study.*

FDA Label Image

Image (Fe05ad15 Db11 4d9e 9fb8 721cec4633d9 143 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.